These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15925697

  • 1. The olfactory bulbectomised rat as a model of depression.
    Song C, Leonard BE.
    Neurosci Biobehav Rev; 2005; 29(4-5):627-47. PubMed ID: 15925697
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
    Jarosik J, Legutko B, Unsicker K, von Bohlen Und Halbach O.
    Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819
    [Abstract] [Full Text] [Related]

  • 3. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
    Iijima M, Chaki S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):622-7. PubMed ID: 17229509
    [Abstract] [Full Text] [Related]

  • 4. The olfactory bulbectomized rat as a model of depression: an update.
    Kelly JP, Wrynn AS, Leonard BE.
    Pharmacol Ther; 1997 Apr 13; 74(3):299-316. PubMed ID: 9352586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The olfactory bulbectomized rat as a model of depression.
    Leonard BE.
    Pol J Pharmacol Pharm; 1984 Apr 13; 36(5):561-9. PubMed ID: 6099892
    [Abstract] [Full Text] [Related]

  • 7. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression.
    Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE.
    Neuroimmunomodulation; 2007 Apr 13; 14(2):65-71. PubMed ID: 17713352
    [Abstract] [Full Text] [Related]

  • 8. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
    Hellweg R, Zueger M, Fink K, Hörtnagl H, Gass P.
    Neurobiol Dis; 2007 Jan 13; 25(1):1-7. PubMed ID: 16990008
    [Abstract] [Full Text] [Related]

  • 9. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A, Yamada M, Yamada M, Takahashi K, Yamaguchi K, Murasawa H, Nakatani A, Tatsumi Y, Hirose N, Kamei J.
    Brain Res; 2008 May 07; 1208():160-9. PubMed ID: 18381208
    [Abstract] [Full Text] [Related]

  • 10. Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression.
    Pistovcakova J, Dostalek M, Sulcova A, Jezova D.
    Pharmacopsychiatry; 2008 Mar 07; 41(2):54-9. PubMed ID: 18311685
    [Abstract] [Full Text] [Related]

  • 11. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment.
    Norrholm SD, Ouimet CC.
    Synapse; 2001 Dec 01; 42(3):151-63. PubMed ID: 11746712
    [Abstract] [Full Text] [Related]

  • 12. Enhanced susceptibility to periodontitis in an animal model of depression: reversed by chronic treatment with the anti-depressant tianeptine.
    Breivik T, Gundersen Y, Myhrer T, Fonnum F, Osmundsen H, Murison R, Gjermo P, von Hörsten S, Opstad PK.
    J Clin Periodontol; 2006 Jul 01; 33(7):469-77. PubMed ID: 16820034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The olfactory bulbectomized rat as a model of depression: The hippocampal pathway.
    Morales-Medina JC, Iannitti T, Freeman A, Caldwell HK.
    Behav Brain Res; 2017 Jan 15; 317():562-575. PubMed ID: 27633561
    [Abstract] [Full Text] [Related]

  • 16. Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice.
    Carlini VP, Machado DG, Buteler F, Ghersi M, Ponzio MF, Martini AC, Schiöth HB, de Cuneo MF, Rodrigues AL, de Barioglio SR.
    Peptides; 2012 Jun 15; 35(2):160-5. PubMed ID: 22525660
    [Abstract] [Full Text] [Related]

  • 17. Behavioural changes following olfactory bulbectomy in rats: a possible model for the detection of antidepressant drugs [proceedings].
    van Riezen H, Schnieden H, Wren A.
    Br J Pharmacol; 1976 Jul 15; 57(3):426P-427P. PubMed ID: 974328
    [No Abstract] [Full Text] [Related]

  • 18. [The behavioral and biochemical sequelae of the removal of the olfactory bulbs in C57Bl/6j mice].
    Gurevich EV, Bobkova NV, Katkov IuA, Otmakhova NA, Nesterova IV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992 Jul 15; 42(4):779-87. PubMed ID: 1332299
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the effects of anosmia induced by either peripheral lesion or bulbectomy upon the feeding pattern of the rat (author's transl)].
    Larue C.
    J Physiol (Paris); 1975 Nov 15; 70(3):299-306. PubMed ID: 1206593
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.
    Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ.
    Pharmacol Biochem Behav; 2005 Sep 15; 82(1):200-6. PubMed ID: 16171853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.